Published in J Virol on August 01, 2005
Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA. J Biol Chem (2009) 1.04
Hepatitis C virus translation inhibitors targeting the internal ribosomal entry site. J Med Chem (2013) 1.00
Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNA. J Virol (2008) 0.93
Targeting ribosome assembly on the HCV RNA using a small RNA molecule. RNA Biol (2012) 0.81
Specific sequence of a Beta turn in human la protein may contribute to species specificity of hepatitis C virus. J Virol (2014) 0.80
A La autoantigen homologue is required for the internal ribosome entry site mediated translation of giardiavirus. PLoS One (2011) 0.79
Exploring Internal Ribosome Entry Sites as Therapeutic Targets. Front Oncol (2015) 0.78
Catalytic metallodrugs based on the LaR2C peptide target HCV SLIV IRES RNA. Dalton Trans (2015) 0.75
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89
Internal ribosome entry site within hepatitis C virus RNA. J Virol (1992) 9.14
Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol (1993) 8.47
A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev (1998) 7.72
Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev (2001) 7.60
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 6.96
Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol (1993) 5.08
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med (1989) 4.69
Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res (1992) 4.58
Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J (1995) 4.44
Specific interaction of eukaryotic translation initiation factor 3 with the 5' nontranslated regions of hepatitis C virus and classical swine fever virus RNAs. J Virol (1998) 3.33
The pathway of HCV IRES-mediated translation initiation. Cell (2004) 2.72
TAT-mediated protein transduction into mammalian cells. Methods (2001) 2.64
The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc Natl Acad Sci U S A (1997) 2.43
Internal translation initiation on poliovirus RNA: further characterization of La function in poliovirus translation in vitro. J Virol (1994) 2.30
Hepatitis C-associated hepatocellular carcinoma. Hepatology (1990) 2.07
Heterogeneous nuclear ribonucleoprotein L interacts with the 3' border of the internal ribosomal entry site of hepatitis C virus. J Virol (1998) 2.00
Eukaryotic transcription termination factor La mediates transcript release and facilitates reinitiation by RNA polymerase III. Mol Cell Biol (1994) 1.94
La autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro. Mol Cell Biol (2004) 1.87
Functional analysis of the interaction between HCV 5'UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nucleic Acids Res (1998) 1.72
Ribosomal protein S5 interacts with the internal ribosomal entry site of hepatitis C virus. J Biol Chem (2001) 1.71
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J Virol (1994) 1.70
The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy. J Viral Hepat (1999) 1.58
Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. J Biol Chem (2000) 1.54
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology (1994) 1.53
Interaction of poly(rC)-binding protein 2 with the 5'-terminal stem loop of the hepatitis C-virus genome. Virus Res (2001) 1.22
A carboxy-terminal basic region controls RNA polymerase III transcription factor activity of human La protein. Mol Cell Biol (1997) 1.21
Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by specific interaction of independent regions of human La autoantigen. J Biol Chem (2003) 1.20
Binding of the La autoantigen to the hepatitis C virus 3' untranslated region protects the RNA from rapid degradation in vitro. J Gen Virol (2001) 1.13
La protein binding at the GCAC site near the initiator AUG facilitates the ribosomal assembly on the hepatitis C virus RNA to influence internal ribosome entry site-mediated translation. J Biol Chem (2004) 1.11
The ribosome binding site of hepatitis C virus mRNA. J Virol (2001) 1.08
The sequence element of the internal ribosome entry site and a 25-kilodalton cellular protein contribute to efficient internal initiation of translation of hepatitis C virus RNA. J Virol (1997) 1.07
Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation. Nucleic Acids Res (2003) 1.06
Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA. J Gen Virol (1999) 1.03
Inhibition of hepatitis C virus IRES-mediated translation by small RNAs analogous to stem-loop structures of the 5'-untranslated region. Nucleic Acids Res (2004) 1.00
A 25 kDa cleavage product of polypyrimidine tract binding protein (PTB) present in mouse tissues prevents PTB binding to the 5' untranslated region and inhibits translation of hepatitis A virus RNA. Virus Res (2003) 0.86
Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci (2005) 2.37
Age-related alterations in default mode network: impact on working memory performance. Neurobiol Aging (2008) 2.11
Neurophysiological correlates of age-related changes in working memory capacity. Neurosci Lett (2005) 2.06
Two internal ribosome entry sites mediate the translation of p53 isoforms. EMBO Rep (2006) 1.64
Brain regions underlying response inhibition and interference monitoring and suppression. Eur J Neurosci (2006) 1.51
La autoantigen is required for the internal ribosome entry site-mediated translation of Coxsackievirus B3 RNA. Nucleic Acids Res (2002) 1.37
Functional, structural, and metabolic abnormalities of the hippocampal formation in Williams syndrome. J Clin Invest (2005) 1.30
Functional changes in the activity of brain regions underlying emotion processing in the elderly. Psychiatry Res (2005) 1.28
Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by specific interaction of independent regions of human La autoantigen. J Biol Chem (2003) 1.20
Age-related alterations in simple declarative memory and the effect of negative stimulus valence. J Cogn Neurosci (2009) 1.17
Polypyrimidine tract binding protein regulates IRES-mediated translation of p53 isoforms. Cell Cycle (2008) 1.14
La protein binding at the GCAC site near the initiator AUG facilitates the ribosomal assembly on the hepatitis C virus RNA to influence internal ribosome entry site-mediated translation. J Biol Chem (2004) 1.11
Catechol-O-methyltransferase valine(158)methionine polymorphism modulates brain networks underlying working memory across adulthood. Biol Psychiatry (2009) 1.08
Preferential amygdala reactivity to the negative assessment of neutral faces. Biol Psychiatry (2009) 1.01
Inhibition of hepatitis C virus IRES-mediated translation by small RNAs analogous to stem-loop structures of the 5'-untranslated region. Nucleic Acids Res (2004) 1.00
Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis. Sci Rep (2013) 0.99
Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses. FEMS Microbiol Lett (2004) 0.97
Effect of mutations on the p53 IRES RNA structure: implications for de-regulation of the synthesis of p53 isoforms. RNA Biol (2011) 0.97
Interplay between NS3 protease and human La protein regulates translation-replication switch of Hepatitis C virus. Sci Rep (2011) 0.96
Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNA. J Virol (2008) 0.93
Targeted delivery of hepatitis C virus-specific short hairpin RNA in mouse liver using Sendai virosomes. J Gen Virol (2009) 0.92
Annexin A2 and PSF proteins interact with p53 IRES and regulate translation of p53 mRNA. RNA Biol (2012) 0.91
Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source. Virus Res (2011) 0.91
Translational control of the interferon regulatory factor 2 mRNA by IRES element. Nucleic Acids Res (2007) 0.90
IRES mediated translational regulation of p53 isoforms. Wiley Interdiscip Rev RNA (2013) 0.87
A 25 kDa cleavage product of polypyrimidine tract binding protein (PTB) present in mouse tissues prevents PTB binding to the 5' untranslated region and inhibits translation of hepatitis A virus RNA. Virus Res (2003) 0.86
Analysis of mutations within the 5' untranslated region, interferon sensitivity region, and PePHD region as a function of response to interferon therapy in hepatitis C virus-infected patients in India. J Clin Microbiol (2006) 0.86
Polypyrimidine tract-binding protein interacts with coxsackievirus B3 RNA and influences its translation. J Gen Virol (2010) 0.86
Neurophysiological correlates of age-related changes in working memory updating. Neuroimage (2012) 0.85
Leader RNA of Rinderpest virus binds specifically with cellular La protein: a possible role in virus replication. Virus Res (2004) 0.84
Human La protein interaction with GCAC near the initiator AUG enhances hepatitis C Virus RNA replication by promoting linkage between 5' and 3' untranslated regions. J Virol (2013) 0.83
Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication. J Gen Virol (2008) 0.81
Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson's disease. Schizophr Res (2013) 0.81
Targeting ribosome assembly on the HCV RNA using a small RNA molecule. RNA Biol (2012) 0.81
An apical GAGA loop within 5' UTR of the coxsackievirus B3 RNA maintains structural organization of the IRES element required for efficient ribosome entry. RNA Biol (2006) 0.81
Specific sequence of a Beta turn in human la protein may contribute to species specificity of hepatitis C virus. J Virol (2014) 0.80
Cryptic AUG is important for 48S ribosomal assembly during internal initiation of translation of coxsackievirus B3 RNA. J Gen Virol (2011) 0.78
Role of polypyrimidine tract binding protein in mediating internal initiation of translation of interferon regulatory factor 2 RNA. PLoS One (2009) 0.78
The structure and function of a cis-acting element located upstream of the IRES that influences Coxsackievirus B3 RNA translation. Virology (2008) 0.78
A cyclic peptide mimic of an RNA recognition motif of human La protein is a potent inhibitor of hepatitis C virus. Antiviral Res (2013) 0.77
Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system. PLoS One (2013) 0.77
Structural and molecular basis of interaction of HCV non-structural protein 5A with human casein kinase 1α and PKR. BMC Struct Biol (2012) 0.76
Efficient dendrimer-DNA complexation and gene delivery vector properties of nitrogen-core poly(propyl ether imine) dendrimer in mammalian cells. Bioconjug Chem (2013) 0.76
A galactose-functionalized dendritic siRNA-nanovector to potentiate hepatitis C inhibition in liver cells. Nanoscale (2015) 0.76
Immunocompetent mouse models to evaluate intrahepatic T cell responses to HCV vaccines. Hum Vaccin Immunother (2014) 0.76
Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy. Mol Ther (2012) 0.75